The Organization for Economic Cooperation and Development (OECD) has published a report on the results of the implementation the Mexican Institute of Social Security (IMSS) of a series of recommendations for the improvement of tenders for medicines and supplies, promoting greater transparency and competition, while combating collusion.
IMSS is the largest social security system in Mexico, serving more than 80 million affiliates, and is the second largest public buyer of healthcare products in the country.
The report evaluates the status and implementation of the OECD’s 2011 recommendations, looking at the impact of changes made to public procurement practices within the IMSS and provides an action plan on how to implement further recommendations. The OECD confirmed the positive impact derived from the implementation of the recommendations issued in the previous edition of this report in 2011.
The study called, “Combatting collusion in public purchases for the IMSS: Impact of the OECD recommendations”, can be consulted at http://oe.cd/imss18es
Full Content: IMSS
Featured News
FTC Pushes Review of CoStar’s Commercial Real Estate Antitrust Case
Jan 31, 2024 by
CPI
UK’s CMA Investigates Ardonagh’s Atlanta Group and Markerstudy Merger
Jan 31, 2024 by
CPI
Greenberg Traurig Grow Financial Regulatory and Compliance Practice
Jan 31, 2024 by
CPI
Dutch Regulator Fines Uber €10 Million for Privacy Violations
Jan 31, 2024 by
CPI
DOJ Investigates AI Competition, Eyes Microsoft’s OpenAI Deal: Bloomberg
Jan 31, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – The Rule(s) of Reason
Jan 29, 2024 by
CPI
Evolving the Rule of Reason for Legacy Business Conduct
Jan 29, 2024 by
CPI
The Object Identity
Jan 29, 2024 by
CPI
In Praise of Rules-Based Antitrust
Jan 29, 2024 by
CPI
The Future of State AG Antitrust Enforcement and Federal-State Cooperation
Jan 29, 2024 by
CPI